New hope for blood cancer patients after GSK’s Blenrep drug receives positive results
Blood cancer drug receives positive headline resultsMultiple myeloma is third biggest blood cancer globallyTrials stopped early than scheduledPharmaceutical company GSK?s (GSK) blood cancer drug Blenrep got a reprieve on Monday...
27 November 2023